Related Experiment Videos
[Gynecomastia and Leydig cell tumor, clinically occult]
A Nubiola Calonge1, L C Valladares, N Jové Vidal
1Servicio de Medicina Interna, Hospital del Espíritu Santo, Santa Coloma de Gramanet, Barcelona, España.
Archivos Espanoles De Urologia
|September 1, 1996
Summary
Diagnosing occult Leydig cell tumors requires hormonal evaluation and scrotal ultrasound, even without palpable testicular abnormalities. This aids in identifying rare testicular tumors presenting with subtle symptoms like gynecomastia.
Area of Science:
- Endocrinology
- Urologic Oncology
- Diagnostic Imaging
Background:
- Leydig cell tumors are rare testicular neoplasms.
- Clinically occult presentations pose diagnostic challenges.
- Gynecomastia can be a presenting symptom of Leydig cell tumors.
Observation:
- A case of clinically occult Leydig cell tumor of the testis is presented.
- The patient's primary symptom was a long history of gynecomastia.
- No testicular anomalies were detected on palpation.
Findings:
- Hormonal studies are crucial for diagnosing Leydig cell tumors.
- Scrotal ultrasound is essential for identifying testicular lesions.
- Early diagnosis is critical despite subtle clinical signs.
Implications:
- Hormonal assessment and scrotal ultrasound should be standard in evaluating unexplained gynecomastia.
- This approach can improve the detection rate of occult testicular tumors.
- Timely diagnosis impacts patient management and prognosis.